Stock Earnings

Question 1

What are Prelude Therapeutics Inc's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), Prelude Therapeutics Inc has a total asset of $175, Net loss of $-127

Question 2

What are the key financial ratios for PRLD?

Accepted Answer

Prelude Therapeutics Inc's Current ratio is 3.97, has a Net margin is -1,814.28, sales per share of $0.09.

Question 3

How is Prelude Therapeutics Inc's revenue broken down by segment or geography?

Accepted Answer

Prelude Therapeutics Inc largest revenue segment is Precision Oncology Therapies, at a revenue of 7,000,000 in the most earnings release.For geography, United States is the primary market for Prelude Therapeutics Inc, at a revenue of 7,000,000.

Question 4

Is Prelude Therapeutics Inc profitable?

Accepted Answer

no, according to the latest financial statements, Prelude Therapeutics Inc has a net loss of $-127

Question 5

Does Prelude Therapeutics Inc have any liabilities?

Accepted Answer

yes, Prelude Therapeutics Inc has liability of 44

Question 6

How many outstanding shares for Prelude Therapeutics Inc?

Accepted Answer

Prelude Therapeutics Inc has a total outstanding shares of 55.14

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	--	7	0	0	0	0
Revenue Growth (YoY)	--	--	--	--	--	--
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Selling, General & Admin	--	28	28	30	26	10
Research & Development	--	117	103	92	86	48
Operating Expenses	--	146	132	123	113	58
Other Non Operating Income (Expenses)	--	12	10	8	2	1
Pretax Income	--	-127	-121	-115	-111	-56
Income Tax Expense	--	--	--	--	--	--
Net Income	--	-127	-121	-115	-111	-56
Net Income Growth	--	5%	5%	4%	98%	107%
Shares Outstanding (Diluted)	--	75.8	60.35	47.37	46.05	12.48
Shares Change (YoY)	--	26%	27%	3%	269%	192%
EPS (Diluted)	--	-1.67	-2.01	-2.44	-2.43	-4.56
EPS Growth	--	-17%	-17%	0%	-47%	-28.99%
Free Cash Flow	-108	-103	-110	-86	-85	-46
Free Cash Flow Per Share	--	-1.35	-1.82	-1.81	-1.84	-3.68
Gross Margin	--	--	--	--	--	--
Operating Margin	--	-1,985.71%	0%	0%	0%	0%
Profit Margin	--	-1,814.28%	0%	0%	0%	0%
Free Cash Flow Margin	--	-1,471.42%	0%	0%	0%	0%
EBITDA	--	-138	-131	-122	-113	-58
EBITDA Margin	--	-1,971.42%	0%	0%	0%	0%
D&A For EBITDA	1	1	1	1	0	0
EBIT	--	-139	-132	-123	-113	-58
EBIT Margin	--	-1,985.71%	0%	0%	0%	0%
Effective Tax Rate	--	--	--	--	--	--

Prelude Therapeutics Inc (PRLD) Price

PRLD Stock Price Chart

PRLD Income

Follow-Up Questions